Advertisement
Collaboration › Details
United Kingdom (govt)–Microsaic: mass spectrometry, 201803– collab evaluating Microsaic MS for online QC in biopharma production at CPI Darlington
Period | 2018-03-23 | |
Region | United Kingdom (town unspecified) | |
Country | United Kingdom (GB) | |
Partner, 1st | Centre for Process Innovation (CPI), National Biologics Manufacturing Centre, Darlington | |
Group | United Kingdom (GB) (govt) | |
Partner, 2nd | Microsaic Systems plc (AIM: MSYS) | |
Product | mass spectrometry-based analysis of biopharmaceutical | |
Product 2 | biopharmaceutical | |
Microsaic Systems plc. (3/23/18). "Press Release: Microsaic Signs Commercial Contract with CPI Innovation Services Ltd".
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce a commercial contract with UK based technology and innovation centre, the Centre for Process Innovation (CPI).
The project will focus on examining the potential of the Microsaic Mass Spectrometry (MS) offering as an online, deployable tool for the elucidation of biopharmaceutical or biologic structure during the manufacturing or bioprocessing workflow. Microsaic’s technology is a powerful point of use analysis tool which can be integrated into complex manufacturing workflows, which has the potential to be utilised in upstream cell media, or downstream biologic purification. A typical workflow could benefit from real-time data to drive production optimisation, ensure process control compliance, and reduce risk for the final product.
CPI brings together state of the art facilities and technical expertise to help companies overcome innovation challenges in the manufacture of biologics. CPI is the UK’s national technology and innovation centre for the process manufacturing industries. At the National Biologics Manufacturing Centre in Darlington, UK, CPI combines state of the art facilities and technical expertise to support the growth and development of the UK biologics industry and supply chain.
Glenn Tracey, CEO, commented “The UK is well positioned as one of the leading countries for process innovation, especially for high value biologics. It is fitting, therefore, that two high-technology businesses such as Microsaic and CPI, both based in the UK, should embark on such exciting knowledge-based work, paving the way for enabling technologies to meet the future quality and compliance needs in biopharma.”
For more information, please contact:
Microsaic Systems plc
Glenn Tracey, COO
Bevan Metcalf, FD
+44 (0) 1483 751577
IFC (Financial PR)
Graham Herring
Heather Armstrong
Florence Chandler
+44 (0)20 7638 9571
N+1 Singer (Nominated
Adviser & Broker)
Shaun Dobson
Liz Yong
+44 (0) 20 7496 3000
Record changed: 2018-04-13 |
Advertisement
More documents for United Kingdom (GB) (govt)
- [1] Earlybird VC Management GmbH & Co KG. (2/14/24). "Press Release: Earlybird Health Closes Fresh Fund of EUR 173m". Berlin & Cologne....
- [2] UK Government (Dept. for Science, Innovation and Technology). (12/5/23). "Press Release: Government Publishes £2 Billion Vision for Engineering Biology to Revolutionise Medicine, Food and Environmental Protection"....
- [3] Cresset Biomolecular Discovery Ltd.. (10/18/23). "Press Release: Cresset Targets International Growth with Innovate UK Scaleup Programme". Cambridge....
- [4] Exscientia plc. (10/17/23). "Press Release: Parker Moss to Join Exscientia as EVP, Corporate Development". Oxford....
- [5] Medicines Discovery Catapult (MDC). (10/5/23). "Press Release: UK Launches Its First National Total-body PET Platform for Drug Discovery"....
- [6] NK:IO Ltd.. (7/11/23). "Press Release: Imperial Spinout NK:IO Awarded £1.6M Innovate UK New Cancer Therapeutics Grant for Development of Pioneering NK Cell Therapy". London....
- [7] BioNTech SE. (1/6/23). "Press Release: BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030". Mainz....
- [8] Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise"....
- [9] Medicines Discovery Catapult (MDC). (8/11/22). "Press Release: Medicines Discovery Catapult and Zeiss Set Sights on Advancing Microscopy. Driving the Application of Microscopy in Drug Discovery"....
- [10] Francis Crick Institute Ltd., The. (7/11/22). "Press Release: £1billion Invested in the Future of UK Discovery Science"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top